CI in single-sided deafness

The cochlear implant (CI) as a treatment option for single-sided deafness (SSD) started with clinical study looking in to the influence of implantation MED-EL device on incapacitating unilateral tinnitus SSD. began 2003 and was conducted by P. Van de Heyning his team Antwerp, Belgium. first CI SSD without Germany implanted J. Mueller R. Jacob Koblenz 2005. Translational research activities took place since then evaluate not only adults but also children. They assessed hearing performance patients CI, importance long electrode arrays patients, degree acceptance children, early children developing language skills, music enjoyment two ears evidence spiral ganglion cell body distribution. In 2013, manufacturer receive CE mark indication asymmetric loss (AHL) 2019, get its approved over age five AHL, FDA USA. This article covers milestones translational from concept widespread use